Zdrowie i gospodarka · 17/01/2025
FDA Extends Comment Period for Expedited Program for Serious Conditions Draft Guidance
The FDA is extending the comment period for the draft guidance on Expedited Program for Serious Conditions--Accelerated Approval of Drugs and Biologics, originally published in the Federal Register on December 6, 2024, to allow more time for industry comments.